Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 209.6321 deferred stock units, convertible to common stock, on November 29, 2024.

Summary

• Jeffrey N. Simmons, CEO of Elanco Animal Health, acquired 209.6321 deferred stock units on November 29, 2024.
• These deferred stock units can be converted into shares of Elanco common stock or their cash equivalent.
• The units will settle in cash or shares after termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
• The price of the underlying common stock at the time of the transaction was $13.21.
• Following the transaction, Mr. Simmons directly owns 4,534.0491 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to slightly positive as it aligns management interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of deferred stock units by the CEO could be seen as a positive sign of confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

This is a routine filing related to executive compensation and is common in publicly traded companies. It reflects the company's compensation strategy and alignment of executive interests with shareholder value.

Comparison to Industry Standards

• Stock-based compensation, including deferred stock units, is a common practice among publicly traded companies, particularly in the pharmaceutical and animal health sectors.
• Companies like Zoetis and IDEXX Laboratories also use similar compensation methods to incentivize their executives.
• The specific terms of the deferral and vesting schedules are typically aligned with industry norms and company-specific performance goals.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with the company's performance.

Key Dates

Keywords

Elanco, Deferred Stock Units, CEO, Jeffrey N. Simmons, Stock Acquisition, Executive Compensation, Form 4, Insider Trading